Home >> Research Area >>PI3K/Akt/mTOR Signaling>>PDK-1>> BX517(PDK1 inhibitor2)

BX517(PDK1 inhibitor2)

PDK1 inhibitor CAS# 850717-64-5

BX517(PDK1 inhibitor2)

Catalog No. BCC6391----Order now to get a substantial discount!

Product Name & Size Price Stock
BX517(PDK1 inhibitor2): 5mg $391 In Stock
BX517(PDK1 inhibitor2): 10mg Please Inquire In Stock
BX517(PDK1 inhibitor2): 20mg Please Inquire Please Inquire
BX517(PDK1 inhibitor2): 50mg Please Inquire Please Inquire
BX517(PDK1 inhibitor2): 100mg Please Inquire Please Inquire
BX517(PDK1 inhibitor2): 200mg Please Inquire Please Inquire
BX517(PDK1 inhibitor2): 500mg Please Inquire Please Inquire
BX517(PDK1 inhibitor2): 1000mg Please Inquire Please Inquire
Related Products

Quality Control of BX517(PDK1 inhibitor2)

Number of papers citing our products

Chemical structure

BX517(PDK1 inhibitor2)

3D structure

Chemical Properties of BX517(PDK1 inhibitor2)

Cas No. 850717-64-5 SDF Download SDF
PubChem ID 11161844 Appearance Powder
Formula C15H14N4O2 M.Wt 282.3
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 27 mg/mL (95.64 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name [(3Z)-2-oxo-3-[1-(1H-pyrrol-2-yl)ethylidene]-1H-indol-5-yl]urea
SMILES CC(=C1C2=C(C=CC(=C2)NC(=O)N)NC1=O)C3=CC=CN3
Standard InChIKey DFURSNCTQGJRRX-JYRVWZFOSA-N
Standard InChI InChI=1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8-
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of BX517(PDK1 inhibitor2)

DescriptionBX517 is a potent and selective inhibitor of PDK1 with IC50 of 6 nM.In Vitro:BX-517 blocks activation of Akt in tumor cells, is potent with IC50 of 0.1-1.0 μM[1]. BX-517 blocks AKT2 activation in cells with submicromolar potency. BX-517 is 100-fold selective or better against a panel of seven additional Ser/Thr and Tyr kinases[2].

References:
[1]. Islam I, et al. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3819-25. [2]. Islam I, et al. Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: design, synthesis and biological activity. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3814-8.

BX517(PDK1 inhibitor2) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

BX517(PDK1 inhibitor2) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of BX517(PDK1 inhibitor2)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.5423 mL 17.7117 mL 35.4233 mL 70.8466 mL 88.5583 mL
5 mM 0.7085 mL 3.5423 mL 7.0847 mL 14.1693 mL 17.7117 mL
10 mM 0.3542 mL 1.7712 mL 3.5423 mL 7.0847 mL 8.8558 mL
50 mM 0.0708 mL 0.3542 mL 0.7085 mL 1.4169 mL 1.7712 mL
100 mM 0.0354 mL 0.1771 mL 0.3542 mL 0.7085 mL 0.8856 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on BX517(PDK1 inhibitor2)

BX-517 is a potent and selective inhibitor of PDK1 that binds to the ATP binding pocket

of the protein (IC50 = 6 nM). BX-517 also blocks activation of Akt in tumor cells with 10-fold more potent (IC50 = 0.1–1.0 μM) than its analogs tested at the highest dose tested (10 μM). [1] The phosphoinositide-dependent kinase-1 (PDK1) is a Ser/Thr kinase that is a crucial activator of a range of protein kinases in the AGC kinase super-family that play key roles in the progression of cancer and for the activation of Akt, S6 kinase, and protein kinase C. [2]

References:
1.  Islam I, Brown G, Bryant J et al. Indolinone based phosphoinositide-dependent
kinase-1 (PDK1) inhibitors.  Part 2: optimization of BX-517. Bioorg Med Chem Lett.
2007 Jul 15;17(14):3819-25. 
2.  Islam I, Bryant J, Chou YL etc. Indolinone based phosphoinositide-dependent kinase-1 (PDK1)
inhibitors.  Part 1: design, synthesis and biological activity. Bioorg Med Chem Lett. 2007 Jul 15;17(14):3814-8.

Featured Products
New Products
 

Description

BX517 is a potent and selective inhibitor of PDK1 with IC50 of 6 nM.

Keywords:

BX517(PDK1 inhibitor2),850717-64-5,Natural Products,PDK-1, buy BX517(PDK1 inhibitor2) , BX517(PDK1 inhibitor2) supplier , purchase BX517(PDK1 inhibitor2) , BX517(PDK1 inhibitor2) cost , BX517(PDK1 inhibitor2) manufacturer , order BX517(PDK1 inhibitor2) , high purity BX517(PDK1 inhibitor2)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: